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Introduction: The identification and treatment of hospitalized patients with community-
acquired urinary tract infections (CAUTI) may be a challenge. The pathogens causing the infection
and their relative proportions vary geographically and with time. This observational prospective
study had three primary goals: (1) to estimate the likelihood of diagnosis of CAUTI upon
admission; (2) to evaluate adherence to the institutional recommendations; (3) to assess the
compatibility of the current local antibiotic recommendations with a pathogen’s distribution and
with its drug sensitivities.
Methods and results: Two hundred and twenty-three patients with positive urinary cultures
fulfilling criteria for CAUTI were studied. Only 54 (24.2%) were diagnosed as having a urinary tract
infection upon admission. Approximately 90% of the patients, who were correctly diagnosed,
received the institutional recommended antibiotic therapy (ofloxacin or cefuroxime). Gram-
negative intestinal flora comprised 86.1% (192 patients) of the causative microorganisms. Of
these, 20.3% of the pathogens demonstrated resistance to ofloxacin and 19.8% to cefuroxime. The
prevalence of Escherichia coli, the most common pathogen of UTI, significantly declined in the
current study, from 70.5% in 1991 to 56% in 2000.
Conclusions: We observed a low sensitivity in diagnosing community-acquired urinary tract
infections upon admission. In patients correctly diagnosed, the use of recommended antibiotics
was high. A substantial percentage of the pathogens were resistant to the recommended
antibiotics. This study stresses the need for frequent re-evaluation of the prevalence of
pathogens involved in regional community-acquired urinary tract infections and the adjustment
of the empirical first-line treatment accordingly.
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Urinary tract infections (UTI) are the most common form of
bacterial infections, affecting people throughout their life-
span.1,2 The term UTI covers a variety of clinical entities,
ranging from cystitis and prostatitis to pyelonephritis. UTI are
more common in females, except in the elderly. As many as
50—80% of women experience at least one episode of UTI
during their lifetime, most of which present as uncompli-
cated cystitis.1—3 In a recent prospective cohort study of
sexually active healthy women, the incidence of acute cysti-
tis was 50—70 episodes per 100 person-years.4
Years of antibiotic over-prescription and abuse on the one
hand, and a decline in the development of novel antibiotics
on the other, have led to a tendency among physicians to shy
away from prompt and aggressive prescription of these
drugs.5,6 This is especially the case with broad-spectrum
antibiotics. The predicted changes in pathogens and in their
occurrencemakes it highly advisable that empirical, first-line
antibiotic treatment should be reviewed periodically in every
regional tertiary medical center.5,7—9 To this end, rigorous,
periodical re-evaluation of regional protocols for empirical
treatment of community-acquired ascending urinary tract
infections (CAUTI) should be performed in every major com-
munity or tertiary medical center, and its conclusions used as
guidelines for that institution as well as for primary clinics
and secondary community centers.5,6,9,10 Longitudinal time
studies may give important indications on ‘changes in trends’
of the common pathogens and provide improved early tools
to combat them.
A CAUTI, especially when complicated, may be a poten-
tially life-threatening condition;2,10,11 therefore adequate
early empiric treatment is essential and may prevent or
reduce morbidity and mortality.2,11 Early diagnosis of
patients on the more severe side of the spectrum of CAUTIFigure 1 Diagnostic steps in this study(pyelonephritis) is difficult and many times is done only after
obtaining results from urine or blood cultures, and in some
cases not made at all.11,12 Hence, it is critical to reassess the
initial, empirical treatment and its efficacy with reference to
the patient status.9,13,14
The pathogens causing UTI may be found along the entire
urinary tract and therefore it is accepted that the entire tract
be considered as a single afflicted entity.2 Patients hospita-
lized with CAUTI are usually regarded as severe cases and are
in need of intravenous antibiotic therapy.2,3,9
Recent studies have demonstrated that the epidemiology
of bacteria causing CAUTI varies from country to country and
even between regional hospitals.5—7 Therefore, our observa-
tional prospective study was designed:1. Tof ho determine the frequency of CAUTI diagnosed as such,
prior to a positive urinary culture.2. To determine the proportion of CAUTI cases that received
a ‘first-line antibiotic’ according to current local recom-
mendations.3. To assess the incidence of the most common uropatho-
gens in our local cases of CAUTI.4. To assess the compatibility of present local antibiotic
guidelines and the level of adherence, with the preva-
lence of bacteria in our region.Materials and methods
The study was performed at the Soroka University Medical
Center, a 1000-bed university-affiliated referral center in
Southern Israel, serving a population of 750 000. The study
was conducted prospectively throughout 2000 and included
hospitalized patients meeting the following inclusion cri-
teria: (1) oral body temperature of 38.2 8C; (2) at leastospital UTI (number of patients).
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flank pain, costovertebral angle tenderness; (3) positive
urine culture (over 105 CFUs) of a single pathogen obtained
upon admission.12,13 A complicated urinary tract infection
was defined as CAUTI on admission in males, pregnant
women, diabetics, immunosuppressed patients, or in
patients with a structural or obstruction abnormality of
the genito-urinary tract.3,13 A patient was categorized into
the dementia group if he was unable to communicate with
the medical staff due to prior neurological deficits unrelated
to the current event or was unable to communicate due to
external circumstances such as mechanical ventilation. The
exclusion criteria were: patients with a permanent urinary
catheter, asymptomatic bacteriuria, and patients with other
suspected sources of infection.
During the study period, 543 single pathogen urine cul-
tures were identified, 198 of which failed to meet the inclu-
sion criteria (Figure 1). Of the remaining 345 patients, 122
cases presented with a positive culture obtained more than
48 hours following admission, therefore they could not be
classified as community-acquired infection and were thus
classified as possible hospital-acquired infections and
excluded from the study.
According to current local recommendations, a quinolone
(IV ofloxacin, 200 mg bid) or an extended spectrum cepha-
losporin (IV cefuroxime, 750 mg tid), were used in our insti-
tution as the empiric first-line antibiotics for hospitalized
CAUTI (presumed to be the more severe cases of CAUTI/
pyelonephritis).9,11
Study patients were identified from positive urinary cul-
ture tests; study-criteria were next confirmed by compre-Table 1 Diagnosis of UTI on admission to the Soroka Medical Ce
All cases n = 223
Female gender, (%) 146 (65.5)
Age, years 64.9  19.2
Recurrent, (%) 64 (28.7)
Previous antibiotic therapy, (%) 25 (11.2)
Dementia, (%) 47 (21.1)
Nursing home, (%) 22 (9.9)
Symptomsa
Burning sensation, (%) 81 (46.0)
Urgency to urinate, (%) 73 (41.5)
Urinate frequently, (%) 51 (29.0)
Flank pain, (%) 73 (41.5)
Complicated UTI, (%) 126 (56.5)
Criteria for complication
Urinary tract problems, (%) 70 (31.4)
Diabetes, (%) 57 (25.6)
Other, (%) 9 (4.0)
Antibiotic therapy
First-line, (%)b 95 (42.6)
Other antibiotics, (%) 49 (22.0)
No antibiotics, (%) 79 (35.4)
a Symptoms were assessed only in 176 patients who were able to co
b Cefuroxime or ofloxacin were considered first-line antibiotics.hensive chart review as well as by patient interview during
the period of hospitalization. Data collected included demo-
graphic details, underlying diseases, symptoms and signs
related to the present infection, diagnosis upon admission,
and initial antibiotic therapy administered within the first
24 hours of admission. Etiological pathogens and their sensi-
tivity to antibiotic therapy were then evaluated. Urine cul-
tures were carried out by our Microbiology Laboratory Service
according to standard techniques.15 Antimicrobial suscept-
ibility tests were performed using the Kirby—Bauer disk
diffusion method16 and interpretation of these tests was
according to the guidelines proposed by the National Com-
mittee for Clinical Laboratory Standards.17 The assay
included eight antibiotics: ampicillin (Amp), ofloxacin (Oflo),
amoxicillin/clavulanate (AM/CL), cefuroxime (Cef), genta-
micin (Gen), nalidixic acid (Nal), trimethoprim/sulfamethox-
azole (TMP/SMX), and nitrofurantoin (Nit). Enteric Gram-
negative flora were defined as pathogens from one of the
following identified species: Escherichia coli, Proteus mir-
abilis, Morganella morganii, Pseudomonas aeruginosa, Kleb-
siella spp, and Enterobacter spp.
This was an observational study and the authors did not
interfere with clinical decisions or with the selection of
antibiotics. The study protocol was approved by the Institu-
tional Helsinki Ethical Committee.
Data analysis
Bivariate hypotheses involving continuous variables were
tested using the Student’s t test for independent groups with
normal distribution. Normality of the study data was testednter during 2000
Diagnosis on admission p Value
UTI n = 54 Other n = 169
34 (63.0) 112 (66.3) 0.66
62.9  22.3 65.6  18.0 0.37
31 (57.4) 33 (19.5) <0.001
8 (14.8) 17 (10.1) 0.33
12 (22.2) 35 (20.7) 0.81
10 (18.5) 12 (7.1) 0.01
31 (73.8) 50 (37.3) <0.001
25 (59.5) 48 (35.8) 0.01
15 (35.7) 36 (26.9) 0.27
22 (52.4) 51 (38.1) 0.09
32 (59.3) 94 (55.6) 0.64
19 (35.2) 51 (30.2) 0.49
14 (25.9) 43 (25.4) 0.94
1 (1.9) 8 (4.7) 0.69
42 (77.8) 53 (31.4) <0.001
8 (14.8) 41 (24.3)
4 (7.4) 75 (44.4)
mmunicate.
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Table 2 Baseline characteristics of the patient population according to the decision for antibiotic therapy upon admission
Any antibiotic treatment n = 144 No antibiotics n = 79 p Value
Female gender, (%) 89 (61.8) 57 (72.2) 0.12
Age, years 63.9  20.1 66.8  17.3 0.28
Recurrent, (%) 51 (35.4) 13 (16.5) 0.003
Previous antibiotic therapy, (%) 22 (15.3) 3 (3.8) 0.01
Dementia, (%) 27 (18.8) 20 (25.3) 0.25
Nursing home, (%) 14 (9.7) 8 (10.1) 0.92
Complicated UTI, (%) 84 (58.3) 42 (53.2) 0.46
Criteria for complication
Urinary tract problems, (%) 56 (38.9) 14 (17.7) 0.001
Diabetes, (%) 27 (18.8) 30 (38.0) 0.002
Other, (%) 7 (4.9) 2 (2.5) 0.50
Figure 2 Classification of pathogens on urine culture. Relative
distribution of microorganisms identified in 223 cases of hospital
UTI at the Soroka Medical Center during 2000. Other microorgan-
isms included Acinetobacter (6), Enterobacter (9), coagulase
negative staphylococci (3), Morganella (4), Strep B (1), and
Citrobacter (1).with a 1-sample Kolmogorov—Smirnov test to indicate the
appropriateness of parametric testing. For tests of whether
the distribution of categorical variables differed across study
groups the Chi-square test was used.
Logistic regression models were used for multivariate
analysis. All the variables found to correlate significantly
with outcome in univariate analysis with p value less than
0.1 were included in the multivariate analysis. In order to
minimize potential confounders, all variables with uneven
distribution between two groups were also included in the
multivariate analysis.
Results
The study included 223 patients; only 54 (24.2%) were diag-
nosed as having a CAUTI upon admission while 155 (69.5%)
were so diagnosed on discharge.
Thedemographicdataandclinical informationaccording to
the diagnosis upon admission are presented in Table 1. As
comparedwith patients diagnosed asUTI subsequent to admis-
sion, the group of patients diagnosed as CAUTI upon admission
had a significantly higher rate of recurrence and complained
more frequently of a burning sensation and a need to urinate.
Of the 223 patients only 176 (78.9%) were able to commu-
nicate; failure to discuss complaints and symptomswas usually
associated with dementia within the group of older CAUTI
patients. Within this group, 42 patients diagnosed as CAUTI on
admission had a median of two complaints as compared with
one complaint in patients not diagnosed on admission
(p < 0.001). Of the 126 patients fulfilling the criteria for
complicated UTI, only 25.4% were so diagnosed on admission.
Although the fraction of patients from nursing homes was only
9.9% of the study population,within this subpopulation, CAUTI
was more readily recognized in these patients (p < 0.01).
Patients diagnosed upon admission with CAUTI received
first-line antibiotic therapy at a higher rate than non-first-line
therapy (77.8% vs. 14.8%, p < 0.001).
Multivariate analysis (logistic regression) revealed four
factors associated with early diagnosing of CAUTI (upon
admission): (1) recurrence (odds ratio 3.4; 95% CI 1.5—
7.6); (2) burning sensation (odds ratio 4.4; 95% CI 1.9—
10.2); (3) urgency to urinate (odds ratio 2.8; 95% CI 1.2—
6.4); (4) flank pain (odds ratio 4.8; 95% CI 2.0—11.7).
Data in Table 2 outline the patient population stratified by
the decision made by the admitting physician to start admin-istering antibiotic treatment. Of the 223 cases studied, 95
(42.6%) received a first-line antibiotic therapy for CAUTI
recommended in our institution (cefuroxime or ofloxacin);
an additional 49 (22.0%) received a different type of anti-
biotic and 79 (35.4%) did not receive any antibiotic therapy in
the first 24 hours of hospitalization. As might be expected, a
history of UTI or CAUTI could be seen as a major contributing
factor affecting the decision of the admitting physician to
initiate antibiotic drug therapy.
Figure 2 shows the breakdown of the pathogens found in
urinary cultures of the patients included in this study. As
expected, Gram-negative intestinal flora comprised 86.1%
(192 patients) of the offending microorganisms. Patients with
Gram-negative enteric pathogens were somewhat older
(66.2  19.1 vs. 56.9  18.0 years, p = 0.01) and had a higher
rate of recurrence (30.7% vs. 16.1%, p = 0.09).
Pathogen sensitivities in this study are shown in Table 3.
The gastrointestinal tract is the most common source of
pathogens in UTI; of the 192 cases of enteric pathogen
cultures, 20.3% demonstrated resistance to ofloxacin,
19.8% were resistant to cefuroxime, and 15.6% demonstrated
resistance to gentamicin. Enteric pathogen cultures resistant
to both ofloxacin and cefuroxime were found in 19 cases
(9.9%). As compared with the rest of the cohort, the subgroup
Regional community-acquired UTI in Israel 249
Table 4 Characteristics of the patient population according to sensitivity of bacteria to first-line antibiotics
Sensitive to first-line
antibiotics n = 180
Resistant to first-line
antibiotics n = 43
p Value
Female gender, (%) 123 (68.3) 23 (53.5) 0.07
Age, years 64.9  19.0 65.1  20.2 0.96
Recurrent, (%) 52 (28.9) 12 (27.9) 0.89
Previous antibiotic therapy, (%) 18 (10) 7 (16.3) 0.24
Dementia, (%) 36 (20) 11 (25.6) 0.42
Nursing home, (%) 15 (8.3) 7 (16.3) 0.11
Complicated UTI, (%) 97 (53.9) 29 (67.4) 0.10
Complications
Urinary pathway problems, (%) 55 (30.6) 15 (34.9) 0.58
Diabetes, (%) 47 (26.1) 10 (23.3) 0.70
Other, (%) 6 (3.3) 3 (7.0) 0.38















Cefuroxime 157 (70.4) 114 (91.2) Not tested Not tested 18 (78.3) 12 (75.0) 12 (50.0)
Ofloxacin 157 (70.4) 102 (81.6) 10 (66.7) Not tested 17 (73.9) 12 (75.0) 16 (66.7)
Gentamicin 177 (79.4) 108 (86.4) 1 (6.7) Not tested 17 (73.9) 7 (43.8) 18 (75.0)
TMP/SMX 115 (51.6) 72 (57.6) 1 (6.7) Not tested 17 (73.9) 7 (43.8) 18 (75.0)
TMP/SMX, trimethoprim/sulfamethoxazole.
a Other microorganisms included Acinetobacter (6), Enterobacter (9), coagulase negative staphylococci (3), Morganella (4), Strep B (1),
and Citrobacter (1).of patients with double antibiotic resistance was older
(75.7  16.0 vs. 65.2  19.1 years, p = 0.02), predominantly
male (57.9% vs. 30.1%, p = 0.02), andmost were nursing home
residents (36.8% vs. 8.7%, p < 0.001). Within the subgroup of
20 cases of CAUTI caused by Enterococcus, all microorgan-
isms were sensitive to vancomycin, 18 (90%) were ampicillin
sensitive, and nine (45%) were sensitive to gentamicin. As can
be seen in Table 4, no significant difference in resistance to
the two first-line antibiotics was observed between CAUTI
and hospital-acquired UTI: in 29 out of 126 patients (23%)
with complicated CAUTI, we identified pathogens with resis-
tance to both first-line antibiotics, whereas 14 of 97 cultures
(14.4%) of the non-complicated CAUTI showed resistance to
both first-line antibiotics ( p = 0.10).Discussion
When assessing the data collected in the present study, three
major issues emerged:1. We observed a low rate of diagnosis of CAUTI upon
admission and prior to receiving a positive urine culture
result.2. When examining the group as a whole, the overall use of a
first-line antibiotic upon admission was low; however, in
cases diagnosed upon admission as CAUTI, the use of a
first-line antibiotic was significantly higher.3. A substantial percentage of the pathogens identified in our
study population were resistant to first-line antibiotics,
significantly more so in patients with complicated CAUTI.Only 24.2% of the CAUTI were identified prior to a positive
urine culture result, despite the fact that most of these
patients presented with fever and urinary tract symptoms.
More importantly, only 69.5% of cases were diagnosed and
listed as CAUTI upon discharge. The latter can partly be
attributed to early discharge, prior to the return of the
urinary culture result. One may predict that the introduction
of automation into analysis and on-line data transfer would
most likely improve the rate of early identification of CAUTI.
Patients diagnosed as CAUTI upon admission received a
first-line antibiotic at a much higher rate (77.8%), than the
group of undiagnosed patients (31.4%). This clearly suggests
that inadequate diagnosis upon admission is to blame rather
than staff failure to comply with the guidelines.
Considering the entire case record covered in this study,
the first-line CAUTI antibiotics (ofloxacin or cefuroxime)
appear inappropriate for 14% of the non-complicated CAUTI.
We observed an even higher rate of resistance to either one
of the first-line antibiotics in the group of complicated CAUTI:
cultures of 23% of the patients with complicated CAUTI were
resistant to both first-line antibiotics. Therefore, this study
suggests that, as far as our center and our region is con-
cerned, patients presenting with complicated CAUTI failed to
receive adequate antibiotic coverage in almost 25% of admis-
sions.
A major incentive for this study was to monitor regional
changes in UTI pathogens. Thus, and despite the obvious
reservation for protocol differences, a study done in this
region in 1995,18 already pointed to a trend of decline in
Gram-negative enteric pathogens in urine cultures of sus-
pected UTI patients in our community clinics. Over a period
250 L. Nesher et al.of four years, that study reported a significant decline in E.
coli positive cultures (70.5% to 61.2%) and a decline in
Proteus mirabilis, Morganella morganii, and Pseudomonas
aeruginosa and a rise in frequency of Klebsiella spp and
Enterobacter spp. Also, resistance to first line antibiotics
has increased in this study as compared with the report by
Weber et al.18 Thus, probable regional changes in pathogens
and in their sensitivities to first line antibiotics should clearly
be the motivation for periodical analyses such as this.
Patients who were included in this study were mostly from
the severe end of the spectrum of CAUTI including pyelone-
phritis and urosepsis, since patients suffering from simple
cystitis or uncomplicated CAUTI or young patients with acute
pyelonephritis are usually managed on an outpatient basis.
One clear limitation of this study relates to its observa-
tional nature; this may have caused some cases to be missed
or misclassified as CAUTI. As many as 47 patients suffered
from cognitive impairment that hindered the communication
of their symptoms. This group of patients was included in the
study after alternative sources of infection were ruled out.
However, these patients were excluded from the specific
analysis of symptoms and complaints.
In summary:1. Resistance to first-line antibiotics was more common
among males than females (38% vs. 8%).2. A higher rate of resistance to antibiotics was observed in
complicated UTI as compared to non-complicated UTI
(24% vs. 15%, relative risk 1.6).3. In our institution, only a small percentage of the UTI
patients were treated with a first-line antibiotic; we
believe that this was due to failure of appropriate diag-
nosis of CAUTI upon admission. We observed a trend of
increased antibiotic resistance in our local pathogens,
specifically in males and in complicated CAUTI patients.
To meet such changes, similar studies should be repeated
at regular intervals.4. A combination of two antibiotics should be considered in
cases of complicated UTI and in male patients with
CAUTI.5. Prompt diagnosis assists in providing adequate antibiotic
therapy, which may reduce in-hospital mortality from
CAUTI.Conflict of interest: No conflict of interest to declare.
References
1. Foxman B. Epidemiology of urinary tract infections: incidence,
morbidity, and economic costs. Am J Med 2002;113(Suppl 1A):
5S—13S.2. Barnett BJ, Stephens DS. Urinary tract infection: an overview.
Am J Med Sci 1997;314:245—9.
3. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam
Physician 1999;59:1225—34. 37.
4. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Staple-
ton AE, et al. A prospective study of risk factors for symptomatic
urinary tract infection in young women. N Engl J Med 1996;
335:468—74.
5. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resis-
tance and the management of uncomplicated community-
acquired urinary tract infections. Ann Intern Med 2001;135:
41—50.
6. Manges AR, Johnson JR, Foxman B, O’Bryan TT, Fullerton KE,
Riley LW. Widespread distribution of urinary tract infections
caused by a multidrug-resistant Escherichia coli clonal group.
N Engl J Med 2001;345:1007—13.
7. Colodner R, Keness Y, Chazan B, Raz R. Antimicrobial suscept-
ibility of community-acquired uropathogens in northern Israel.
Int J Antimicrob Agents 2001;18:189—92.
8. Huang ES, Stafford RS. National patterns in the treatment of
urinary tract infections in women by ambulatory care physicians.
Arch Intern Med 2002;162:41—7.
9. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ,
Stamm WE. Guidelines for antimicrobial treatment of uncom-
plicated acute bacterial cystitis and acute pyelonephritis in
women. Infectious Diseases Society of America (IDSA). Clin
Infect Dis 1999;29:745—58.
10. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the
misuse of culture results and antibiotic sensitivities in patients
with community-acquired bacteraemia due to urinary tract
infection. J Infect 1997;35:283—8.
11. Rubenstein JN, Schaeffer AJ. Managing complicated urinary
tract infections: the urologic view. Infect Dis Clin North Am
2003;17:333—51.
12. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the
clinical diagnosis of acute pyelonephritis. Am J Emerg Med
1997;15:148—51.
13. Hooton TM, Stamm WE. Diagnosis and treatment of uncompli-
cated urinary tract infection. Infect Dis Clin North Am 1997;
11:551—81.
14. Saint S, Scholes D, Fihn SD, Farrell RG, Stamm WE. The effec-
tiveness of a clinical practice guideline for the management of
presumed uncomplicated urinary tract infection in women. Am J
Med 1999;106:636—41.
15. Pezzlo M. Clinical microbiology procedures handbook. Washing-
ton, D.C., USA: American Society for Microbiology; 1992.
16. Bauer AW, KirbyWM, Sherris JC, Turck M. Antibiotic susceptibility
testing by a standardized single disk method. Am J Clin Pathol
1966;45:493—6.
17. NCCLS. Performance standards for antimicrobial disk suscept-
ibility tests. Fifth edition; approved standard. NCCLS document
M2-A5. Villa-Nova, Pennsylvania, USA: NCCLS; 1993.
18. Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky
P. Changing trends in frequency and antimicrobial resistance of
urinary pathogens in outpatient clinics and a hospital in Southern
Israel, 1991—1995. Eur J Clin Microbiol Infect Dis 1997;16:
834—8.
